These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 56853)

  • 21. Effect of alpha-methyl-p-tyrosine on 3,4-dihydroxyphenylalanine (DOPA) excretion of hamsters with melanotic melanoma.
    Voorhess ML
    Cancer Res; 1968 Mar; 28(3):452-4. PubMed ID: 5640864
    [No Abstract]   [Full Text] [Related]  

  • 22. The separation and identification of dopamine 3-O-sulfate and dopamine 4-O-sulfate in urine of Parkinsonian patients.
    Bronaugh RL; Hattox SE; Hoehn MM; Murphy RC; Rutledge CO
    J Pharmacol Exp Ther; 1975 Dec; 195(3):441-52. PubMed ID: 1195131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the excretion of different types of melanogens in the melanoma patients.
    Matous B; Pavel S; Budĕsínská A; Duchon J; Mechl Z; Sopková B
    Neoplasma; 1979; 26(5):597-602. PubMed ID: 118388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biochemical diagnosis of pheochromocytoma, neuroblastoma and other neuro-ectodermal neoplasms].
    Käser H
    Helv Paediatr Acta; 1972; 29():Suppl 29:1-114. PubMed ID: 4661091
    [No Abstract]   [Full Text] [Related]  

  • 25. Failure of enzyme inhibition therapy for malignant melanoma.
    Greer M; Anton AH; Williams CM
    Trans Am Neurol Assoc; 1969; 94():273-5. PubMed ID: 5374459
    [No Abstract]   [Full Text] [Related]  

  • 26. Diffuse melanosis and trichochromuria in malignant melanoma.
    Agrup G; Agrup P; Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1979; 59(5):456-7. PubMed ID: 93371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Urinary excretion of 3,4-dihydroxyphenylalanine (DOPA) and dopamine in hamsters with induced or transplanted melanomas].
    Aubert C; Bohuon C; Comoy E
    C R Acad Hebd Seances Acad Sci D; 1969 Jun; 268(23):2850-2. PubMed ID: 4977597
    [No Abstract]   [Full Text] [Related]  

  • 28. 3,4-Dihydroxyphenylalanine in the urine of patients with ocular malignant melanoma.
    Kruszczyński T
    Pol Med J; 1972; 11(6):1507-11. PubMed ID: 4659074
    [No Abstract]   [Full Text] [Related]  

  • 29. The urinary melanogen cysteinyldopa in melanoma and in suntanning: Australian experience.
    Nixon PF
    Aust N Z J Surg; 1978 Feb; 48(1):17-21. PubMed ID: 276342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary excreion of DOPA and metabolites by patients with melanoma.
    Voorhess ML
    Cancer; 1970 Jul; 26(1):146-9. PubMed ID: 5424526
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of 5,6-dimethoxyindolyl-2-carboxylic acid in melanotic urine.
    Pavel S; Elzinga H; Muskiet FA; Wolthers BG
    Acta Derm Venereol; 1983; 63(4):340-3. PubMed ID: 6195867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of 4-hydroxyanisole: identification of major urinary excretory products.
    Pavel S; Holden JL; Riley PA
    Pigment Cell Res; 1989; 2(5):421-6. PubMed ID: 2587513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of malignant melanoma with DTIC--therapeutic effects determined by 5-S-cysteinyldopa changes in the urine (proceedings)].
    Agrup G; Hafström L; Jönsson PE; Rorsman H
    Lakartidningen; 1978 Dec; 75(49):4599-600. PubMed ID: 364213
    [No Abstract]   [Full Text] [Related]  

  • 34. [1st studies on urinary polyamine excretion in malignant dermatoses].
    Rodermund OE; Moersler B
    Z Hautkr; 1975 Apr; 50(7):273-9. PubMed ID: 132021
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative studies between excretion of 5-S-cysteinyldopa and indole melanogens in urine].
    Beyer C; Fiedler H; Wohlrab W; Wozniak KD
    Dermatol Monatsschr; 1986; 172(9):541-4. PubMed ID: 3098590
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of metabolites of tiropramide in human urine.
    Arigoni R; Chistè R; Makovec F; Setnikar I; Benfenati E; Fanelli R
    Biomed Environ Mass Spectrom; 1988 Feb; 15(4):205-9. PubMed ID: 3370360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary phenols in melanoma.
    Coward RF; Smith P; Middleton JE
    Nature; 1967 Feb; 213(5075):520-1. PubMed ID: 6032242
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of interferon on C19-steroids in urine of malignant skin melanoma and malignant breast neoplasm patients.
    Marković L; Ivanović S; Konstantinović I; Ikić D; Micić J; Stakić B
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):416-8. PubMed ID: 6238002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of trichochromes in the urine of a melanoma patient.
    Prota G; Rorsman H; Rosengren AM; Rosengren E
    Experientia; 1976 Sep; 32(9):1122-4. PubMed ID: 971737
    [No Abstract]   [Full Text] [Related]  

  • 40. Analytic techniques in the separation and identification of specific purine and pyrimidine degradation products of tRNA: application to urine samples from cancer patients.
    Mrochek JE; Dinsmore SR; Waalkes TP
    J Natl Cancer Inst; 1974 Dec; 53(6):1553-63. PubMed ID: 4474409
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.